secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001104659-24-076578
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Carisma Therapeutics appoints Thorell and Scadden to board; Hodits and Odlander resign
--------------------------------------------------------------------------------

- Regina Hodits and Björn Odlander resigned from board effective June 30, 2024, citing other professional commitments, not disagreements.
- Marella Thorell and David Scadden elected as Class III directors, serving until 2026 annual meeting.
- Thorell will chair audit committee; Scadden will chair science committee.
- Each new director receives $40k annual cash retainer and option for 38,700 shares vesting monthly over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/0001104659-24-076578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924076578/tm2418383d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-076578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer